Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intra-Aortic Balloon Pumping | 4 | 2015 | 83 | 0.330 |
Why?
|
Nutrition Therapy | 1 | 2009 | 10 | 0.320 |
Why?
|
Micronutrients | 1 | 2009 | 18 | 0.320 |
Why?
|
Heart, Artificial | 4 | 1992 | 9 | 0.310 |
Why?
|
Heart Transplantation | 7 | 2015 | 769 | 0.300 |
Why?
|
Operating Rooms | 2 | 2018 | 131 | 0.260 |
Why?
|
Postoperative Complications | 7 | 1999 | 2435 | 0.220 |
Why?
|
Heart Atria | 2 | 2015 | 285 | 0.210 |
Why?
|
Myocytes, Cardiac | 2 | 2014 | 317 | 0.180 |
Why?
|
Heart Failure | 4 | 2015 | 1333 | 0.170 |
Why?
|
Lung Transplantation | 3 | 2000 | 345 | 0.170 |
Why?
|
Bronchial Fistula | 1 | 1998 | 9 | 0.150 |
Why?
|
Vascular Fistula | 1 | 1998 | 12 | 0.150 |
Why?
|
Aortic Coarctation | 1 | 1998 | 35 | 0.150 |
Why?
|
Aortography | 1 | 1998 | 65 | 0.150 |
Why?
|
Thoracic Surgery | 1 | 2018 | 49 | 0.150 |
Why?
|
Bronchi | 1 | 1999 | 232 | 0.150 |
Why?
|
Heart | 4 | 1999 | 583 | 0.150 |
Why?
|
Aortic Diseases | 1 | 1998 | 102 | 0.140 |
Why?
|
Patient Handoff | 1 | 2018 | 95 | 0.140 |
Why?
|
Heart-Assist Devices | 4 | 1996 | 862 | 0.130 |
Why?
|
Perioperative Care | 1 | 2018 | 174 | 0.130 |
Why?
|
Organizational Policy | 1 | 1997 | 55 | 0.130 |
Why?
|
Resuscitation Orders | 1 | 1997 | 65 | 0.130 |
Why?
|
Stents | 1 | 1999 | 415 | 0.130 |
Why?
|
Subclavian Artery | 1 | 2015 | 42 | 0.120 |
Why?
|
Critical Care | 1 | 2018 | 399 | 0.120 |
Why?
|
Jehovah's Witnesses | 1 | 2015 | 21 | 0.120 |
Why?
|
Vena Cava, Superior | 1 | 2015 | 60 | 0.120 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2014 | 28 | 0.120 |
Why?
|
Excitation Contraction Coupling | 1 | 2014 | 8 | 0.120 |
Why?
|
Intensive Care Units | 1 | 2018 | 422 | 0.120 |
Why?
|
Societies, Medical | 1 | 2018 | 598 | 0.120 |
Why?
|
Urocortins | 1 | 2014 | 1 | 0.110 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 148 | 0.110 |
Why?
|
Calcium Signaling | 1 | 2014 | 140 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2014 | 50 | 0.110 |
Why?
|
Mediastinitis | 1 | 1992 | 14 | 0.100 |
Why?
|
Pulse | 1 | 1991 | 16 | 0.100 |
Why?
|
Central Venous Pressure | 1 | 1991 | 27 | 0.100 |
Why?
|
Oximetry | 1 | 1991 | 83 | 0.090 |
Why?
|
Bacterial Infections | 1 | 1992 | 184 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 489 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2000 | 2686 | 0.090 |
Why?
|
Coronary Disease | 1 | 1991 | 261 | 0.080 |
Why?
|
Male | 25 | 2015 | 43796 | 0.080 |
Why?
|
Avitaminosis | 1 | 2009 | 5 | 0.080 |
Why?
|
Nutritional Requirements | 1 | 2009 | 17 | 0.080 |
Why?
|
Trace Elements | 1 | 2009 | 11 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2009 | 13 | 0.080 |
Why?
|
Middle Aged | 20 | 2015 | 26991 | 0.080 |
Why?
|
Parenteral Nutrition | 1 | 2009 | 62 | 0.080 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2009 | 59 | 0.080 |
Why?
|
Intestinal Absorption | 1 | 2009 | 125 | 0.080 |
Why?
|
Magnesium | 1 | 1989 | 178 | 0.080 |
Why?
|
Enteral Nutrition | 1 | 2009 | 104 | 0.080 |
Why?
|
Vitamins | 1 | 2009 | 84 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 740 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2009 | 126 | 0.080 |
Why?
|
Potassium | 1 | 2009 | 261 | 0.070 |
Why?
|
Organ Preservation | 1 | 1989 | 131 | 0.070 |
Why?
|
Adult | 17 | 2015 | 27478 | 0.070 |
Why?
|
Oxygen | 1 | 1991 | 760 | 0.070 |
Why?
|
Humans | 26 | 2018 | 92134 | 0.060 |
Why?
|
Myocardium | 1 | 2009 | 584 | 0.060 |
Why?
|
Anastomosis, Surgical | 2 | 2015 | 279 | 0.060 |
Why?
|
Reoperation | 4 | 1998 | 657 | 0.060 |
Why?
|
Aged | 13 | 2015 | 19913 | 0.060 |
Why?
|
Insulin | 1 | 2009 | 1166 | 0.060 |
Why?
|
Female | 19 | 2015 | 47767 | 0.060 |
Why?
|
Vascular Resistance | 2 | 1996 | 104 | 0.050 |
Why?
|
Rabbits | 2 | 2014 | 643 | 0.050 |
Why?
|
Lung Neoplasms | 4 | 2000 | 2394 | 0.050 |
Why?
|
Inflammation | 1 | 2009 | 1020 | 0.050 |
Why?
|
Hemodynamics | 3 | 1996 | 757 | 0.050 |
Why?
|
Preoperative Care | 2 | 2015 | 405 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 1995 | 1139 | 0.040 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2000 | 20 | 0.040 |
Why?
|
Ganglia, Autonomic | 1 | 1999 | 6 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 1999 | 127 | 0.040 |
Why?
|
Histamine | 1 | 1999 | 126 | 0.040 |
Why?
|
Catecholamines | 1 | 1999 | 92 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 1999 | 219 | 0.040 |
Why?
|
Catheterization | 1 | 1999 | 239 | 0.040 |
Why?
|
Patient Transfer | 1 | 2018 | 103 | 0.040 |
Why?
|
Advance Directive Adherence | 1 | 1997 | 6 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2015 | 9619 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 173 | 0.030 |
Why?
|
Ganglia | 1 | 1996 | 14 | 0.030 |
Why?
|
Survival Rate | 4 | 1995 | 1919 | 0.030 |
Why?
|
Thoracotomy | 2 | 1995 | 65 | 0.030 |
Why?
|
Personal Autonomy | 1 | 1997 | 116 | 0.030 |
Why?
|
Withholding Treatment | 1 | 1997 | 117 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 1996 | 66 | 0.030 |
Why?
|
Time Factors | 4 | 1992 | 5425 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2015 | 56 | 0.030 |
Why?
|
Thoracoscopy | 1 | 1994 | 23 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 92 | 0.030 |
Why?
|
Adolescent | 4 | 1999 | 9488 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2015 | 159 | 0.030 |
Why?
|
Mediastinal Diseases | 1 | 1994 | 22 | 0.030 |
Why?
|
Parathyroid Glands | 1 | 1994 | 75 | 0.030 |
Why?
|
Hemoglobins | 1 | 2015 | 193 | 0.030 |
Why?
|
Choristoma | 1 | 1994 | 64 | 0.030 |
Why?
|
Remission Induction | 2 | 1995 | 762 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2014 | 2456 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1997 | 308 | 0.030 |
Why?
|
Informed Consent | 1 | 1997 | 278 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 1997 | 224 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 89 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1993 | 38 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 1995 | 148 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 1993 | 58 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 1993 | 99 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 277 | 0.030 |
Why?
|
Cefazolin | 1 | 1992 | 7 | 0.030 |
Why?
|
Adenoma | 1 | 1994 | 255 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 283 | 0.020 |
Why?
|
Animals | 4 | 2014 | 28052 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 364 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1998 | 1266 | 0.020 |
Why?
|
Vancomycin | 1 | 1992 | 76 | 0.020 |
Why?
|
Catheterization, Swan-Ganz | 1 | 1991 | 24 | 0.020 |
Why?
|
Counterpulsation | 1 | 1991 | 21 | 0.020 |
Why?
|
Femoral Artery | 1 | 1991 | 85 | 0.020 |
Why?
|
Aortic Valve | 1 | 1993 | 256 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1991 | 64 | 0.020 |
Why?
|
Mitral Valve | 1 | 1993 | 272 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 1991 | 62 | 0.020 |
Why?
|
Cause of Death | 1 | 1992 | 271 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 1991 | 109 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1991 | 206 | 0.020 |
Why?
|
Hemolysis | 1 | 1990 | 64 | 0.020 |
Why?
|
Calcium | 1 | 2014 | 1186 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 1995 | 2555 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 1991 | 330 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1991 | 187 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2009 | 39 | 0.020 |
Why?
|
Heart Rate | 1 | 1991 | 502 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2014 | 2911 | 0.020 |
Why?
|
Hemorrhage | 1 | 1990 | 290 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 503 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 320 | 0.020 |
Why?
|
Length of Stay | 1 | 1992 | 796 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1990 | 272 | 0.020 |
Why?
|
Swine | 1 | 2009 | 601 | 0.020 |
Why?
|
Lung | 1 | 1994 | 1334 | 0.020 |
Why?
|
Incidence | 1 | 1992 | 1652 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1992 | 990 | 0.020 |
Why?
|
United States | 2 | 1997 | 7312 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 1995 | 1730 | 0.020 |
Why?
|
Glucose | 1 | 2009 | 684 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 1197 | 0.020 |
Why?
|
Etoposide | 2 | 1995 | 205 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 3508 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 1983 | 36 | 0.010 |
Why?
|
Jejunum | 1 | 1983 | 80 | 0.010 |
Why?
|
Abdominal Injuries | 1 | 1983 | 52 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 8689 | 0.010 |
Why?
|
Cisplatin | 2 | 1995 | 602 | 0.010 |
Why?
|
Feasibility Studies | 2 | 1995 | 793 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1983 | 115 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2000 | 1395 | 0.010 |
Why?
|
Dopa Decarboxylase | 1 | 1999 | 2 | 0.010 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 1999 | 3 | 0.010 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 1999 | 6 | 0.010 |
Why?
|
Histidine Decarboxylase | 1 | 1999 | 6 | 0.010 |
Why?
|
Tryptophan Hydroxylase | 1 | 1999 | 11 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1999 | 44 | 0.010 |
Why?
|
Cross Reactions | 1 | 1999 | 109 | 0.010 |
Why?
|
Acetylcholine | 1 | 1999 | 177 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 1995 | 2035 | 0.010 |
Why?
|
Norepinephrine | 1 | 1999 | 172 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2000 | 333 | 0.010 |
Why?
|
Serotonin | 1 | 1999 | 219 | 0.010 |
Why?
|
Dopamine | 1 | 1999 | 273 | 0.010 |
Why?
|
Indoles | 1 | 1999 | 308 | 0.010 |
Why?
|
Parasympathetic Nervous System | 1 | 1996 | 36 | 0.010 |
Why?
|
Vagus Nerve | 1 | 1996 | 49 | 0.010 |
Why?
|
Methods | 1 | 1995 | 151 | 0.010 |
Why?
|
Heart Conduction System | 1 | 1996 | 118 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 1996 | 161 | 0.010 |
Why?
|
Prospective Studies | 2 | 1994 | 4457 | 0.010 |
Why?
|
Ventricular Fibrillation | 1 | 1995 | 69 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 1996 | 6911 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1994 | 220 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 1994 | 80 | 0.010 |
Why?
|
Regression Analysis | 1 | 1995 | 595 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 1995 | 124 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1996 | 245 | 0.010 |
Why?
|
Electrocardiography | 1 | 1996 | 500 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1993 | 54 | 0.010 |
Why?
|
Heart Diseases | 1 | 1996 | 308 | 0.010 |
Why?
|
Stroke Volume | 1 | 1996 | 493 | 0.010 |
Why?
|
Ohio | 1 | 1993 | 41 | 0.010 |
Why?
|
New York City | 1 | 1993 | 61 | 0.010 |
Why?
|
Washington | 1 | 1993 | 50 | 0.010 |
Why?
|
Decision Trees | 1 | 1993 | 62 | 0.010 |
Why?
|
California | 1 | 1993 | 156 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1999 | 1407 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1993 | 118 | 0.010 |
Why?
|
Aortic Valve Insufficiency | 1 | 1993 | 143 | 0.010 |
Why?
|
Vincristine | 1 | 1991 | 109 | 0.010 |
Why?
|
Illinois | 1 | 1993 | 503 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1993 | 203 | 0.010 |
Why?
|
Prednisone | 1 | 1991 | 256 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1991 | 304 | 0.010 |
Why?
|
Radiotherapy | 1 | 1993 | 325 | 0.010 |
Why?
|
Doxorubicin | 1 | 1991 | 296 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1993 | 278 | 0.010 |
Why?
|
Recurrence | 1 | 1993 | 1179 | 0.010 |
Why?
|
Neurons | 1 | 1999 | 1605 | 0.010 |
Why?
|
Heparin | 1 | 1990 | 188 | 0.010 |
Why?
|
Waiting Lists | 1 | 1990 | 197 | 0.000 |
Why?
|
Graft Rejection | 1 | 1994 | 1096 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1995 | 3766 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1990 | 375 | 0.000 |
Why?
|
Wound Infection | 1 | 1983 | 18 | 0.000 |
Why?
|
Therapeutic Irrigation | 1 | 1983 | 61 | 0.000 |
Why?
|
Peritonitis | 1 | 1983 | 29 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1991 | 3480 | 0.000 |
Why?
|
Child | 1 | 1983 | 7311 | 0.000 |
Why?
|